Human trials on dysregulated nutrient sensing via the mTOR pathway showed significant results, including a 50% reduction in infections after an 8-week treatment. The study by Joan Mannick demonstrated lasting effects for a year. This advances longevity and health research.
Trial Details
The intervention targeted the mTOR pathway, leading to improved immune responses in participants.
Broader Impact
Such findings could influence treatments for age-related diseases, as discussed in recent posts on X.
Source: Posts found on X.